Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 05, 2023, titled "Dr. Reddy s successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumab".
Press Release Jun 05 2023
Filed with NSE · · 4 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release May 10 2023
- Press Release May 05 2023
- Press Release Apr 21 2023
- Press Release Mar 16 2023
- Press Release Feb 27 2023
Later from Dr. Reddy's Laboratories
- Press Release Jun 14 2023
- Press Release Jun 23 2023
- Press Release Jul 12 2023
- Press Release Jul 26 2023
- Press Release Aug 10 2023
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories